Author: Kleinehr, Jens; Wilden, Janine J.; Boergeling, Yvonne; Ludwig, Stephan; Hrincius, Eike R.
Title: Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral Targets Cord-id: cefc5o2w Document date: 2021_10_14
ID: cefc5o2w
Snippet: Respiratory viruses are known to be the most frequent causative mediators of lung infections in humans, bearing significant impact on the host cell signaling machinery due to their host-dependency for efficient replication. Certain cellular functions are actively induced by respiratory viruses for their own benefit. This includes metabolic pathways such as glycolysis, fatty acid synthesis (FAS) and the tricarboxylic acid (TCA) cycle, among others, which are modified during viral infections. Here
Document: Respiratory viruses are known to be the most frequent causative mediators of lung infections in humans, bearing significant impact on the host cell signaling machinery due to their host-dependency for efficient replication. Certain cellular functions are actively induced by respiratory viruses for their own benefit. This includes metabolic pathways such as glycolysis, fatty acid synthesis (FAS) and the tricarboxylic acid (TCA) cycle, among others, which are modified during viral infections. Here, we summarize the current knowledge of metabolic pathway modifications mediated by the acute respiratory viruses respiratory syncytial virus (RSV), rhinovirus (RV), influenza virus (IV), parainfluenza virus (PIV), coronavirus (CoV) and adenovirus (AdV), and highlight potential targets and compounds for therapeutic approaches.
Search related documents:
Co phrase search for related documents- acute sars cov respiratory syndrome coronavirus and adenosine triphosphate: 1, 2, 3, 4, 5, 6
- acute sars cov respiratory syndrome coronavirus and long chain fatty: 1
- acute sars cov respiratory syndrome coronavirus and long term effect: 1, 2, 3, 4, 5, 6, 7
- acute sars cov respiratory syndrome coronavirus and low airway: 1, 2, 3, 4
- acute sars cov respiratory syndrome coronavirus and low infectivity: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute sars cov respiratory syndrome coronavirus and low respiratory tract: 1, 2, 3, 4, 5
- acute sars cov respiratory syndrome coronavirus and low upper respiratory tract: 1, 2
- acute sars cov respiratory syndrome coronavirus and low viral titer: 1, 2, 3
- acute sars cov respiratory syndrome coronavirus and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute sars cov respiratory syndrome coronavirus and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute sars cov respiratory syndrome coronavirus and lung tissue damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute sars cov respiratory syndrome coronavirus and lung viral titer: 1, 2
- acute sars cov respiratory syndrome coronavirus and madin darby: 1
- long term effect and lung infection: 1
- long term effect and lung tissue: 1
- low respiratory tract and lung infection: 1, 2
- low respiratory tract and lung tissue: 1, 2
- lung infection and madin darby: 1
- lung tissue and madin darby: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date